Sign in

CIK 0001347178 · Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
030491827
Phone
202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 8-K Event Results of operations
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 8-K Event Other events
  5. 8-K Event Other events
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Other events
  11. 4 Insider Changes in Ownership
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. 4 Insider Changes in Ownership
  16. 144 Insider Sale of Securities
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 4 of 67 · 1,337 filings